Source comparison
Comparison of TB-500 to Standard Rotator Cuff Treatments
TB-500 Actin upregulation, tenocyte migration, angiogenesis 2–4 weeks (animal models) Moderate (animal studies, limited human data) Research-grade only, not FDA-approved for human use Strongest mechanistic rationale for tissue regeneration but lacks Phase III
This comparison does not assign a generated winner or score.
- TB-500
- Actin upregulation, tenocyte migration, angiogenesis
- 2–4 weeks (animal models)
- Moderate (animal studies, limited human data)
- Research-grade only, not FDA-approved for human use
- Strongest mechanistic rationale for tissue regeneration but lacks Phase III human trials
- Corticosteroid Injection
- Anti-inflammatory, suppresses immune response
- 48–72 hours
- High (extensive clinical use)
- Widely available, covered by insurance
- Rapid symptom relief but evidence shows increased risk of tendon weakening and re-tear
- PRP Injection
- Growth factor delivery via platelet concentrate
- 4–8 weeks
- Moderate (inconsistent trial results)
- Growing availability, often not covered by insurance
- Variable efficacy. Depends on preparation protocol and platelet concentration
- Physical Therapy
- Load management, neuromuscular re-education
- 6–12 weeks
- High (gold standard for partial tears)
- Universally accessible
- Effective for symptom management but does not accelerate biological healing
- Surgical Repair
- Direct tendon reattachment to bone
- 3–6 months full recovery
- High (standard for full-thickness tears)
- Requires specialist, significant recovery time
- Only option for complete tears but 20–40% re-tear rate within 5 years
- The comparison reveals a gap: corticosteroids address symptoms but compromise tissue integrity. PRP aims to enhance healing but shows inconsistent results likely due to platelet preparation variability. Physical therapy manages load but doesn't change the biological healing timeline. TB-500 targets the specific cellular bottlenecks (migration, angiogenesis, collagen organization) that limit natural repair. But human clinical evidence remains preliminary.